Schedule 13G ownership disclosure

HELIX ACQUISITION CORP II

Class A Ordinary Shares, par value $0.0001 per share · CUSIP: G4444H101

Event date: 2025-07-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sculptor Capital LP

    Shares: 967,460 · Class: 5.12%

  • Sculptor Capital II LP

    Shares: 967,460 · Class: 5.12%

  • Sculptor Capital Holding Corp

    Shares: 967,460 · Class: 5.12%

  • Sculptor Capital Holding II LLC

    Shares: 967,460 · Class: 5.12%

  • Sculptor Capital Management, Inc.

    Shares: 967,460 · Class: 5.12%

  • Sculptor Master Fund, Ltd.

    Shares: 967,460 · Class: 5.12%

  • Sculptor Special Funding, LP

    Shares: 967,460 · Class: 5.12%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-098552
Form type
SCHEDULE 13G
Filer
BridgeBio Oncology Therapeutics, Inc.
CIK
CIK 1869105
Filed
Jul 24, 2025
Reporting period
Jul 17, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub